🇺🇸 FDA
Pipeline program

Loperamide

2011CB5200-Fd

Phase 3 small_molecule completed

Quick answer

Loperamide for Diarrhea-predominant Irritable Bowel Syndrome is a Phase 3 program (small_molecule) at Chengdu University of Traditional Chinese Medicine with 1 ClinicalTrials.gov record(s).

Program details

Company
Chengdu University of Traditional Chinese Medicine
Indication
Diarrhea-predominant Irritable Bowel Syndrome
Phase
Phase 3
Modality
small_molecule
Status
completed

Clinical trials